Christine Grimaldi

7PUBLICATIONS
27CO-AUTHORS
Gene and molecular therapyNanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Industrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 19, 2026
Immunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing.

|Aug 04, 2025
Host Cell Protein Clinical Safety Risk Assessment-An Updated Industry Review.

Lisette Coye, Marisa A Jones, Georgeen Gaza-Bulseco

|Feb 08, 2025
IQ Survey Results on Current Industry Practices: Part 2-Quantitative Evaluations of Immunogenicity Assessment.

Susan Richards, Insa Winzenborg, Doreen Luedtke

|Jan 29, 2025
IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk Assessment.

Christine Grimaldi, Susan Richards, Daniel Baltrukonis

|Mar 31, 2023
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics.

Kyle P Martin, Christine Grimaldi, Rolf Grempler

|Apr 23, 2021
Critical reagent generation, characterization, handling and storage workflows: impact on ligand binding assays.

Elisa Oquendo, Jolaine Savoie, Joyce M Swenson

Pageof 2

Frequent Collaborators

2 joint publications

Susan Richards

2 joint publications

Benjamin Wu

1 joint publications

Kyle P Martin

1 joint publications

Rolf Grempler